Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vaccine ; 40(34): 4933-4941, 2022 08 12.
Article in English | MEDLINE | ID: mdl-35810063

ABSTRACT

Subunit influenza vaccine only formulated with surface antigen proteins has better safety profiles relative to split-virion influenza vaccine. Compared to the traditional quadrivalent split-virion influenza vaccine, a novel quadrivalent subunit influenza vaccine is urgently needed in China. We completed a phase 3, randomized, double-blind, active-controlled, non-inferiority clinical study at two sites in Henan Province, China. Eligible volunteers were split into four age cohorts (3-8 years, 9-17 years, 18-64 years, and ≥ 65 years, based on their dates of birth) and randomly assigned (1:1) to the subunit and the split-virion ecNAIIV4 groups. All volunteers were intramuscularly administered a single vaccine dose at baseline, and children aged 3-8 years received a boosting dose at day 28. And the immune response was evaluated by measuring hemagglutinin-inhibition antibody titers against the four vaccine strains in blood samples. Safety profiles had nonsignificant differences between the study groups in ≥ 3 years cohort. Most adverse reactions post-vaccination, both local and systemic, were mild to moderate and resolved within 3 days. And no serious adverse events occurred. The immunogenicity of the trial vaccine was non-inferior to the comparator. Further, a two-dose vaccine series can provide better seroprotection than that of a one-dose series in children aged 3-8 years, with clinically acceptable safety profiles. Clinical Trials Registration. ChiCTR2100049934.


Subject(s)
Influenza Vaccines , Influenza, Human , Antibodies, Viral , Child , Double-Blind Method , Hemagglutination Inhibition Tests , Humans , Immunogenicity, Vaccine , Influenza, Human/prevention & control , Vaccines, Combined , Vaccines, Inactivated
2.
Planta ; 243(4): 1041-53, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26781778

ABSTRACT

MAIN CONCLUSION: The stilbene synthase gene VqSTS6, from Chinese wild type Vitis quinquangularis accession Danfeng-2, increases the resveratrol content and pathogen resistance of transgenic plants of V. vinifera Thompson Seedless. This study successfully created transgenic plants of V. vinifera Thompson Seedless which overexpressed VqSTS6, cloned from Chinese wild type V. quinquangularis accession Danfeng-2. Western blot and qRT-PCR showed a variable range in transcript levels among transgenic lines. The resistance to powdery mildew (Uncinula necator) was particularly enhanced in lines most highly expressing VqSTS6. Compared with the non-transformed controls, trans-resveratrol and other stilbene compounds were significantly increased in the transgenic lines. The correlation between high resveratrol content and high pathogen resistance in transgenic grapes is discussed. We hypothesize that the fruit-specific, highly expressed gene VqSTS6 from Chinese wild V. quinquangularis accession Danfeng-2, is directly involved in the resveratrol synthesis pathway in grapes, and plays an important role in the plant's defense against pathogens. Genetic transformation of VqSTS6 explored the potential of the wild Chinese grape species for use in breeding, the results of which would raise both the disease resistance and the fruit quality of V. vinifera grapevines.


Subject(s)
Acyltransferases/genetics , Fruit/genetics , Plants, Genetically Modified/genetics , Vitis/genetics , Acyltransferases/metabolism , Ascomycota/pathogenicity , Disease Resistance/genetics , Plant Diseases/genetics , Plant Diseases/microbiology , Plants, Genetically Modified/microbiology , Real-Time Polymerase Chain Reaction/methods , Resveratrol , Stilbenes/metabolism , Transformation, Genetic , Vitis/metabolism , Vitis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...